Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion type Assertion NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_head.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion wasGeneratedBy ECO_0000203 NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_provenance.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion wasDerivedFrom befree-20150227 NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_provenance.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion SIO_000772 23595973 NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_provenance.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion evidence source_evidence_literature NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_provenance.
- NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_assertion description "[Does treatment with the insulin sensitizer metformin modify the levels and activation of proteins related to the expression of the insulin-dependent glucose transporter (GLUT4), such as adenosine monophosphate-activated protein kinase (AMPK) and myocyte enhancer factor 2A (MEF2A), in endometria from hyperinsulinemic hyperandrogenemic polycystic ovary syndrome (PCOS h-Ins) patients?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007252.RAUXEVoTR3iJpnWR5qfgEL1lcyy89izP9S4I4KQ10JPvo130_provenance.